Galectin Therapeutics
GALT
GALT
46 hedge funds and large institutions have $3.43M invested in Galectin Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Holders
46
Holding in Top 10
–
Calls
$130K
Puts
$152K
Top Buyers
| 1 | +$147K | |
| 2 | +$114K | |
| 3 | +$66.4K | |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$37.7K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$35K |
Top Sellers
| 1 | -$646K | |
| 2 | -$89K | |
| 3 | -$85K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$54.5K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$44K |